BANKINVEST BIOMEDICAL VENTURE
BankInvest Biomedical Venture makes investments in research-based biotechnology companies in Europe.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-08-18 | F2G | BankInvest Biomedical Venture investment in Venture Round - F2G | 6.3 M GBP |
| 2007-08-09 | Nereus Pharmaceuticals | BankInvest Biomedical Venture investment in Series D - Nereus Pharmaceuticals | 45 M USD |
| 2006-09-26 | Resistentia Pharmaceuticals | BankInvest Biomedical Venture investment in Series C - Resistentia Pharmaceuticals | 13.96 M USD |
| 2005-06-01 | Cellectis | BankInvest Biomedical Venture investment in Series C - Cellectis | 5.6 M EUR |
| 2005-03-01 | LiPlasome Pharma | BankInvest Biomedical Venture investment in Series B - LiPlasome Pharma | 8.01 M USD |
| 2002-05-01 | Cellectis | BankInvest Biomedical Venture investment in Series B - Cellectis | 8 M EUR |
| 2000-12-21 | Oxagen | BankInvest Biomedical Venture investment in Venture Round - Oxagen | 30 M GBP |
| 2000-06-13 | Genmab | BankInvest Biomedical Venture investment in Venture Round - Genmab | 40.5 M USD |
| 1999-05-17 | Genmab | BankInvest Biomedical Venture investment in Venture Round - Genmab | 2 M USD |
More informations about "BankInvest Biomedical Venture"
BankInvest Biomedical Venture - Investments, Portfolio
Aug 18, 2008 BankInvest Biomedical Venture has made 9 investments. Their most recent investment was on Aug 18, 2008, when F2G raised. obfuscated. obfuscated. How many …See details»
BankInvest Biotech Ventures investment portfolio
Dec 18, 2007 BankInvest Biotech Ventures General Information Company Description. BankInvest Biotech Ventures was a venture capital firm that was based in Denmark, Copenhagen. The firm was founded in 1998 and invested …See details»
BI Biomedical Venture IV: Fund Performance - PitchBook
Jan 1, 2004 BI Biomedical Venture IV General Information Description. BI Biomedical Venture IV is a venture capital fund managed by BankInvest Group. The fund is located in Copenhagen, …See details»
BankInvest Biomedical Venture – Investors Database - Unicorn Nest
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019. …See details»
BankInvest - Crunchbase Investor Profile & Investments
BankInvest is an investment management company that offers asset management and investment funds. New. ... Early Stage Venture, Late Stage Venture, Private Equity www.bankinvest.com ; 46,717; Highlights. Investments …See details»
BankInvest BioMedical Venture - VC Firm Profile - Gaebler.com …
BankInvest BioMedical Venture invests in innovation by backing companies focused on high-impact, technology-driven solutions. Venture Investor Overview. Venture Investor. BankInvest …See details»
BankInvest Biomedical Venture | Investor profile | Foundersuite
Today, BankInvest offers investment products ranging from global equities, over emerging market equities and debt via regular bonds to private equity and venture capital funds. Moreover, …See details»
Bankinvest Biomedical Venture | Day of Difference
This BankInvest Biomedical Venture works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in …See details»
BankInvest Biomedical Venture (BI Technology A/S)
Investment activity status. Active investorSee details»
BankInvest Biomedical Venture - Web3 Crypto Company Profile, …
BankInvest Biomedical Venture makes investments in research-based biotechnology companies in Europe.See details»
BankInvest Biomedicinsk Venture I: Fund Performance - PitchBook
Jan 1, 1998 BankInvest Biomedicinsk Venture I was a venture capital fund managed by BankInvest Biotech Ventures. The fund was located in Copenhagen, Denmark. The fund …See details»
Novo Holdings · michael-k-bauer
Michael joined Venture Investments in November 2020. From 2006-2020, Michael was employed at Genmab in various positions with increasing responsibility; starting in Project Management …See details»
BankInvest Biomedical Venture Culture - Comparably
Learn about BankInvest Biomedical Venture's culture, see what work's like, read reviews, and find job opportunities.See details»
Nereus Pharmaceuticals, Inc. Raises $45 Million in Series D
Aug 9, 2007 In conjunction with the financing, the company named Jesper Zeuthen, D.Sc. from Series D-2 lead investor BankInvest Biomedical Venture of Copenhagen to the Nereus board …See details»
BankInvest Group investment portfolio - PitchBook
BankInvest Group General Information Company Description. Founded in 1969, BankInvest Group is a subsidiary of BI Holding based in Copenhagen, Denmark. The firm offers …See details»
Anders Fink Vadsholt - Crunchbase Person Profile
Anders Fink Vadsholt joined BankInvest Biomedical Venture in 2005. Mr. Vadsholt manages a number of Biomedical Venturs investments and serves on the board of Zealand Pharma. He is …See details»
BankInvest Biomedical Venture III - Secondary pricing, deals, …
BankInvest Biomedical Venture III - Secondary pricing, deals, buyers & sellerssecondary pricing. Monitor secondaries news, GP Led and continuation fund secondaries deals. Connect with …See details»
Cellectis closes second financing round - buyoutsinsider.com
Jun 26, 2002 Investee Company – Cellectis SA Investee Company Business Type – Develops technology for genome rewriting Type of Financing – Expansion Equity Providers – BankInvest …See details»
Michael Karl Bauer - BioFIT Speaker
Michael joined Novo Ventures in November 2020. From 2006-2020, Michael was employed at Genmab in various positions with increasing responsibility; ... Prior to Genmab, Michael …See details»